G Medical Innovations IPO Presentation Deck
Summary Balance Sheet and Cap Table
Balance Sheet Data
(As of June 30, 2022)
Cash and cash
equivalents
Total assets
Long term debt
Total shareholders'
equity (deficit)
Actual As Adjusted
$1,509,000 $17,143,000
$10,278,000
$905,000
$(1,240,000)
$25,912,000
$905,000
$15,086,000
Pro Forma, Pre-Offering Cap Table
Ordinary shares outstanding
Options
(WAEP: $58.68)
2
Warrants
(WAEP: $44.59)
Ordinary Shares issuable pursuant
to performance rights ³
Fully Diluted
Ordinary Shares Outstanding
1,963,768
132,421
1,246,448
117,289
3,459,926
1. As adjusted data gives effect to the repayment of the April 2021 Financing Debentures ($600,000 principal plus accrued interest), and the issuance and sale of Ordinary Shares in this offering, at an
assumed public offering price of $3.15 per share, which is the minimum price at which we may issue Ordinary Shares until the approval of our Capital Reduction by the Grand Court of the Cayman
Islands, after deducting underwriting discounts and commissions and estimated offering expenses, as if the sale of the Ordinary Shares had occurred on June 30, 2022.
2. Gives pro forma effect for (i) the anticipated repayment in full of the April 2021 Financing Debentures with the proceeds from this offering by excluding 5,315 ordinary shares issuable upon conversion of
the April 2021 Financing Debentures at a $140.00 per share conversion price, and (ii) includes 515,233 warrants to purchase ordinary shares at an exercise price of $1.94 per share, issuable conditioned
upon the approval of our Capital Reduction by the Grand Court of the Cayman Islands.
3. Classified into ten classes, which vest upon a market capitalization ranging from $75,000,000 to $250,000,000.
21View entire presentation